Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Session Type:

Availability:

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 24 of 24
TUESDAY PLENARY SESSION
THE EMERGING POTENTIAL FOR HIV CURE FOR INFANTS, CHILDREN, AND ADULTS
Jintanat Ananworanich
US Military HIV Research Program, Thai Red Cross, Bethesda, MD, USA
from CROI 2017 on February 14, 2017 8:30 AM-9:30 AM
TUESDAY PLENARY SESSION
ADVANCES IN CELLULAR THERAPY IN CANCER AND HIV
Carl H June
University of Pennsylvania, Philadelphia, PA, USA
from CROI 2017 on February 14, 2017 8:30 AM-9:30 AM
WEDNESDAY PLENARY SESSION
(PREVENTING) THE COMING EPIDEMIC: HIV IN YOUTH
Shannon L Hader
US Centers for Disease Control and Prevention, Atlanta, GA, USA
from CROI 2017 on February 15, 2017 8:30 AM-9:30 AM
WEDNESDAY PLENARY SESSION
ANTIVIRAL VACCINE DEVELOPMENT FROM A (AIDS) TO Z (ZIKA)
Barney S. Graham
NIAID, National Institutes of Health, Bethesda, MD, USA
from CROI 2017 on February 15, 2017 8:30 AM-9:30 AM
THURSDAY PLENARY SESSION
IF YOU CAN MAKE IT THERE: ENDING THE HIV EPIDEMIC IN NEW YORK
Demetre C Daskalakis
NYC Department of Health and Mental Hygiene, New York, NY, USA
from CROI 2017 on February 16, 2017 8:30 AM-9:30 AM
THURSDAY PLENARY SESSION
HTLV-1: THE OTHER HUMAN RETROVIRUS
Charles RM Bangham
Imperial College London, London, United Kingdom
from CROI 2017 on February 16, 2017 8:30 AM-9:30 AM
Plenary
Harnessing Antibodies for HIV-1 Prevention and Treatment
John R. Mascola
Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States
from CROI 2016 on February 23, 2016 8:30 AM-9:00 AM
Plenary
Antiretroviral Therapy: Where Are We Now? Where Are We Going?
Joseph J. Eron
University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
from CROI 2016 on February 23, 2016 9:00 AM-9:30 AM
Plenary
Progress in Gene Therapy for HIV Cure
Paula M. Cannon
University of Southern California, Los Angeles, CA, United States
from CROI 2016 on February 24, 2016 8:30 AM-9:00 AM
Plenary
HIV in Transgender Populations: Charted and Uncharted Waters
Tonia C. Poteat
Johns Hopkins University, Baltimore, MD, United States
from CROI 2016 on February 24, 2016 9:00 AM-9:30 AM
Plenary
Tuberculosis: Why Do I Have to Take So Many Pills?
Eric J. Rubin
Harvard School of Public Health, Boston, MA, United States
from CROI 2016 on February 25, 2016 8:30 AM-9:00 AM
Plenary
The Evolving Epidemiology of HIV Infection in Persons Who Inject Drugs: Indiana 2015
John T. Brooks
Centers for Disease Control and Prevention, Atlanta, GA, United States
from CROI 2016 on February 25, 2016 9:00 AM-9:30 AM
Plenary
PrEP for HIV Prevention: What We Know and What We Still Need to Know for Implementation
Raphael J. Landovitz
University of California Los Angeles, Los Angeles, CA, United States
from CROI 2015 on February 24, 2015 8:30 AM-9:00 AM
Plenary
Specific HIV Integration Sites Linked to Clonal Expansion and Persistence of Cells
Stephen H. Hughes
National Cancer Institute, Frederick, MD, United States
from CROI 2015 on February 24, 2015 9:00 AM-9:30 AM
Plenary
Preventing Pediatric HIV and Managing HIV-Infected Children: Where Are We Now, and Where Are We Going?
Diana M. Gibb
University College London, London, United Kingdom
from CROI 2015 on February 25, 2015 8:30 AM-9:00 AM
Plenary
Directing Chronic Virus Infection Through Viral Regulation of Innate Immune Defenses
Michael Gale
University of Washington, Center for Innate Immunity and Immune Disease, Seattle, WA, United States
from CROI 2015 on February 25, 2015 9:00 AM-9:30 AM
Plenary
Cardiovascular Disease in HIV Patients: An Emerging Paradigm and Call to Action
Steven Grinspoon
Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States
from CROI 2015 on February 26, 2015 8:30 AM-9:00 AM
Plenary
The Price of Selling Sex: HIV Among Female Sex Workers—The Context and the Public Health Response
Frances M. Cowan
University College London, London, United Kingdom
from CROI 2015 on February 26, 2015 9:00 AM-9:30 AM
Plenary
HPV Vaccines: Progress To Date and Future Worldwide Directions
Douglas R. Lowy
National Cancer Institute, Bethesda, MD, United States
from CROI 2014 on March 4, 2014 8:30 AM-9:00 AM
Plenary
HIV in People Who Use Drugs
Adeeba Kamarulzaman
University of Malaya, Kuala Lumpur, Malaysia
from CROI 2014 on March 4, 2014 9:00 AM-9:30 AM
Plenary
B-Cell Responses To HIV Infection: Challenges and Opportunities
Susan L. Moir
National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States
from CROI 2014 on March 5, 2014 8:30 AM-9:00 AM
Plenary
NeuroHIV in 2014: Beyond Dementia
Serena S. Spudich
Yale University, New Haven, CT, United States
from CROI 2014 on March 5, 2014 9:00 AM-9:30 AM
Plenary
HIV-1 Infection and Type-1 Interferon
Michael H. Malim
King's College London, London, United Kingdom
from CROI 2014 on March 6, 2014 8:30 AM-9:00 AM
Plenary
PEPFAR/Global Fund at 10 years: Past, Present, and Future
Stefano M. Bertozzi
University of California Berkeley School of Public Health, Berkeley, CA, United States
from CROI 2014 on March 6, 2014 9:00 AM-9:30 AM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 24 of 24